These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Possible induction to mistake in the dilution of noradrenaline]. Taberner Bonastre P; García Muñoz S; Soriano Clemente A; Soler Company E Farm Hosp; 2013; 37(6):558-9. PubMed ID: 24256020 [No Abstract] [Full Text] [Related]
44. Effects of dobutamine, norepinephrine, and vasopressin on cardiovascular function in anesthetized neonatal foals with induced hypotension. Valverde A; Giguère S; Sanchez LC; Shih A; Ryan C Am J Vet Res; 2006 Oct; 67(10):1730-7. PubMed ID: 17014324 [TBL] [Abstract][Full Text] [Related]
45. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction. Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285 [TBL] [Abstract][Full Text] [Related]
48. Can Vasopressors Safely Be Administered Through Peripheral Intravenous Catheters Compared With Central Venous Catheters? Brewer JM; Puskarich MA; Jones AE Ann Emerg Med; 2015 Dec; 66(6):629-31. PubMed ID: 26210381 [No Abstract] [Full Text] [Related]
49. [Central venous cannulation--the important things, you should know!]. Szibor-Kriesen U; Rücker G; Vagts DA Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Oct; 43(10):654-63. PubMed ID: 18958817 [TBL] [Abstract][Full Text] [Related]
50. Reducing the risks of infiltration and extravasation. Rosenthal K Nursing; 2007; 37 Suppl Med():4-8. PubMed ID: 18163033 [No Abstract] [Full Text] [Related]
51. Should Norepinephrine, Rather than Phenylephrine, Be Considered the Primary Vasopressor in Anesthetic Practice? Mets B Anesth Analg; 2016 May; 122(5):1707-14. PubMed ID: 27101504 [No Abstract] [Full Text] [Related]
52. Differential effects of phenylephrine and norepinephrine on peripheral tissue oxygenation during general anaesthesia: A randomised controlled trial. Poterman M; Vos JJ; Vereecke HE; Struys MM; Vanoverschelde H; Scheeren TW; Kalmar AF Eur J Anaesthesiol; 2015 Aug; 32(8):571-80. PubMed ID: 25760679 [TBL] [Abstract][Full Text] [Related]
53. Indications for peripheral, midline and central catheters: summary of the MAGIC recommendations. Moureau N; Chopra V Br J Nurs; 2016 Apr 28-May 11; 25(8):S15-24. PubMed ID: 27126759 [TBL] [Abstract][Full Text] [Related]
54. The peripheral intravenous catheter: an appropriate yet often overlooked choice for venous access. Gorski LA Home Healthc Nurse; 2009 Feb; 27(2):130-2. PubMed ID: 19212229 [No Abstract] [Full Text] [Related]
55. Cardiac tamponade in a newborn because of umbilical venous catheterization: is correct position safe? Onal EE; Saygili A; Koç E; Türkyilmaz C; Okumus N; Atalay Y Paediatr Anaesth; 2004 Nov; 14(11):953-6. PubMed ID: 15500497 [TBL] [Abstract][Full Text] [Related]
56. Closed-loop vasopressor control: in-silico study of robustness against pharmacodynamic variability. Rinehart J; Joosten A; Ma M; Calderon MD; Cannesson M J Clin Monit Comput; 2019 Oct; 33(5):795-802. PubMed ID: 30539349 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of Risk of Injury by Extravasation of Hyperosmolar and Vasopressor Agents in a Rat Model. Shibata Y; Sagara Y; Yokooji T; Taogoshi T; Tanaka M; Hide M; Matsuo H Biol Pharm Bull; 2018; 41(6):951-956. PubMed ID: 29863084 [TBL] [Abstract][Full Text] [Related]
58. Peripheral administration of vasopressin for catecholamine-resistant hypotension complicated by skin necrosis. Bunker N; Higgins D Crit Care Med; 2006 Mar; 34(3):935; author reply 935-6. PubMed ID: 16505698 [No Abstract] [Full Text] [Related]
59. Complications of Peripheral Venous Access Devices: Prevention, Detection, and Recovery Strategies. Mattox EA Crit Care Nurse; 2017 Apr; 37(2):e1-e14. PubMed ID: 28365664 [TBL] [Abstract][Full Text] [Related]